Arkolith/Insider Trading/AKTX/Form 4

Neal James R

DirectorAkari Therapeutics Plc (AKTX) · full profile →Form 4 · filed Mar 16, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 16, 2025Buy(P)3K——3K
Dec 16, 2025Buy(P)3K$0.40$1K3K
Dec 16, 2025Buy(P)2K——2K
Dec 16, 2025Buy(P)2K$0.40$9892K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-010304) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML